Seriniquinones, melanoma-specific anticancer agents
US-9481662-B2 · Nov 1, 2016 · US
US12534447B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12534447-B2 |
| Application number | US-202117800401-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 17, 2021 |
| Priority date | Feb 17, 2020 |
| Publication date | Jan 27, 2026 |
| Grant date | Jan 27, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to bioconjugates and labeled derivatives of the adducts formed by the reaction of patulin with benzene-1,2-dithiols or their salts. Said conjugates are suitable for the production of antibodies capable of recognizing the aforementioned patulin-(benzene-1,2-dithiols) adducts with high affinity and specificity. Likewise, the present invention also relates to the use of bioconjugates of patulin-(benzene-1,2-dithiols) adducts and of labeled derivatives thereof as assay antigens. Furthermore, the present invention also relates to immunochemical methods for the analysis of patulin, using the bioconjugates and labeled derivatives and antibodies of the invention, which include a previous step to quantitatively convert patulin into these adducts. This invention also provides a kit for analyzing patulin comprising a benzene-1,2-dithiol or its salts, antibodies against patulin-(benzene-1,2-dithiols) adducts, and assay antigens.
Opening claim text (preview).
The invention claimed is: 1 . A bioconjugate of general formula (I): [T-L-Z] m —P (I) where: T is selected from the group consisting of the radicals R-I and R-II wherein R 1 , R 2 , R 3 , and R 4 are independently selected from H, substituted or unsubstituted aryl groups, linear or branched alkyl groups of 1 to 6 carbon atoms, OMe, OEt, OPr, C≡N, CO 2 H, CO 2 -alkyl of 1 to 6 carbon atoms, NO 2 , NH 2 , F, Cl, Br, and I L is a hydrocarbon chain, saturated or unsaturated, of 0 to 14 carbon atoms, where the chain is linear or branched, and said hydrocarbon chain comprises the substitution of between 0 and 7 carbon atoms by heteroatoms, which are selected from the group consisting of S, O and N, Z is a functional group selected from: —NH—, —NH(C═O)—, —NH(C═O)O—, —(C═O)NH—, —(C═O)O—, —O(C═O)—, —O(C═O)O—, —O(C═O)NH—, —S—, P is a natural or synthetic peptide or polypeptide, or a protein, with a molecular weight greater than 2000 daltons, m is a number with a value between 1 and 500. 2 . The bioconjugate of formula (I) according to claim 1 wherein L is a linear hydrocarbon chain of 0 to 7 carbon atoms and said hydrocarbon chain comprises the substitution of between 0 and 3 carbon atoms by heteroatoms selected from the group consisting of O and N. 3 . The bioconjugate of formula (I) according to claim 1 , characterized in that Z is selected from the group consisting of: —NH—, —NH(C═O)—, —(C═O)NH—, 4 . The bioconjugate of formula (I) according to claim 1 characterized in that L is a linear hydrocarbon chain of 0 to 3 carbon atoms and said hydrocarbon chain comprises the substitution of between 0 and 2 carbon atoms by heteroatoms selected from the group consisting of O and N. 5 . The bioconjugate of formula (I) according to claim 1 characterized in that Z is —(C═O)NH—. 6 . The bioconjugate of formula (I) according to claim 1 , characterized in that P is selected from the group consisting of albumin, thyroglobulin, hemocyanin, beta-galactosidase, phosphatase, peroxidase, and oxidase. 7 . The bioconjugate of formula (I) according to claim 1 , characterized in that m is a number with a value between 1 and 50. 8 . The bioconjugate of formula (I) according to claim 1 , having the formula (Ia) where P is selected from the group consisting of albumin or peroxidase, and m is a value selected between 1 and 50. 9 . The bioconjugate of formula (I) according to claim 1 , having the formula (Ib) where P is selected from the group consisting of albumin or peroxidase, and m is a value selected between 1 and 50. 10 . The bioconjugate of formula (I) according to claim 1 , having the formula (Ic) where P is selected from the group consisting of albumin or peroxidase, m is a value selected between 1 and 50, and where R 2 is CH 3 and R 3 is H, or R 2 is H and R 3 is CH 3 . 11 . The bioconjugate of formula (I) according to claim 1 , having the formula (Id) where P is selected from the group consisting of albumin or peroxidase, and m is a value selected between 1 and 50. 12 . The bioconjugate of formula (I) according to claim 1 , having the formula (Ie) where P is selected from the group consisting of albumin or peroxidase, and m is a value selected between 1 and 50. 13 . The bioconjugate of formula (I) according to claim 1 , having the formula (If) where P is selected from the group consisting of albumin or peroxidase, and m is a value selected between 1 and 50, and where R 2 is CH 3 and R 3 is H, or R 2 is H and R 3 is CH 3 . 14 . The bioconjugate of formula (I) according to claim 1 , having the formula (Ig) where P is selected from the group consisting of albumin or peroxidase, and m is a value selected between 1 and 50. 15 . The bioconjugate of formula (I) according to claim 1 , having the formula (Ih) where P is selected from the group consisting of albumin or peroxidase, and m is a value selected between 1 and 50. 16 . The bioconjugate of formula (I) according to claim 1 , having the formula (Ii) where P is selected from the group consisting of albumin or peroxidase, m is a value selected between 1 and 50, and where R 2 is CH 3 and R 3 is H, or R 2 is H and R 3 is CH 3 . 17 . A labeled derivative of formula (II): [T-L-Z] n -Q (II) wherein, T and L have been defined according to claim 1 ; Z has been defined in claim 1 ; Q is a detectable label and n is a number with a value between 1 and 500. 18 . The labeled derivative of formula (II) according to claim 17 , where Q is selected from the group consisting of enzymes, biotin, fluorescein or any one of its derivatives, a cyanine fluorophore, a rhodamine fluorophore, a coumarin fluorophore, a ruthenium bipyryl, luciferin or any one of its derivatives, an acridinium ester, quantum nanoparticles (quantum dots), and micro- or nanoparticles of colloidal gold, carbon, or latex. 19 . The labeled derivative of formula (II) according to claim 17 characterized in that Z is selected from the group consisting of —NH—, —NH(C═O)—, —(C═O)NH—, 20 . The bioconjugate of formula (II) according to claim 17 , characterized in that m is a number with a value between 1 and 50. 21 . The labeled derivative of formula (II) according to claim 17 , having the formula (IIa) where Q is selected from the group consisting of peroxidase, biotin, fluorescein, or gold nanoparticles, and n is a value selected between 1 and 10. 22 . The labeled derivative of formula (II) according to claim 17 , having the formula (IIb) where Q is selected from the group consisting of peroxidase, biotin, fluorescein, or gold nanoparticles, and n is a value selected between 1 and 10. 23 . The labeled derivative of formula (II) according to claim 17 , having the formula (IIc)
Fruits or vegetables · CPC title
against material not provided for elsewhere {, e.g. haptens, metals, DNA, RNA, amino acids} · CPC title
Six-membered rings · CPC title
involving hydrolase · CPC title
involving oxidoreductase · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.